6505--763-25-1-021-0002 -Lancaster CMOP SUMATRIPTAN -(VA-25-00009226)

The Department of Veterans Affairs Veterans Health Administration (VA VHA) is seeking to procure Sumatriptan medication for the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) through a competitive small business solicitation. The procurement is specifically for pharmaceutical preparation manufacturing under NAICS code 325412 and Product Service Code 6505, targeting drug and biological supply needs. The solicitation (ID: 36C77025Q0048) will be managed by the VA NCO 15 Contracting Office located in Leavenworth, Kansas, with Contracting Specialist Kayla Powers serving as the primary point of contact. Responses to this pre-solicitation notice are due by December 11, 2024, at 17:00 Central Time, with interested small businesses expected to submit comprehensive proposals demonstrating capability to fulfill the medication supply requirements. While specific evaluation criteria are not explicitly detailed in the pre-solicitation notice, typical VA procurement processes generally assess vendor qualifications, pricing, delivery capabilities, and compliance with pharmaceutical manufacturing standards.

The contract opportunity is explicitly set aside exclusively for small businesses, which significantly narrows the competitive field for potential bidders. The place of performance is designated as the VA CMOP Lancaster facility located at 2962 S. Longhorn Drive in Lancaster, Texas 75134. While exact award values or precise quantity requirements are not specified in the current documentation, pharmaceutical contracts with VA facilities typically involve substantial volume commitments to ensure consistent medication supply for veterans' healthcare needs. The December 3, 2024 posting date suggests this is a near-term procurement with an anticipated contract award in the first quarter of 2025. Potential vendors should carefully review the full solicitation documentation when released and prepare comprehensive proposals that demonstrate their ability to meet the VA's stringent pharmaceutical supply requirements.